ERIC WEST: Open Payments
NPI 1255375226 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 20 payments from 10 companies in 2025. Trend: 2023 $428 · 2024 $355 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $77 |
| PFIZER INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Exact Sciences Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, PREVNAR 20, AIRSUPRA, FARXIGA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, Kerendia, Rybelsus.
Industry payments across OK — which companies pay providers there.
